US Patent 11926657 Neutralizing anti-influenza binding molecules and uses thereof
Patent 11926657 was granted and assigned to MedImmune, LLC on March, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 14 Mar, 2024
Golden AI
Edits made to:
Infobox (+24 properties)
Article (+308 characters)
US Patent 11926657 Neutralizing anti-influenza binding molecules and uses thereof
Article
Patent abstract
Binding molecules, including bispecific antibodies that include at least two anti-influenza binding domains are disclosed, including binding molecules having a first binding domain that specifically binds influenza A virus and a second binding domain that specifically binds influenza B virus.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Changshou Gao0
Cuihua Gao0
Godfrey Jonah Rainey0
Nicole Kallewaard-Lelay0
Qing Zhu0
Srinath Kasturirangan0
Date of Patent
March 12, 2024
0Patent Application Number
180547570
Date Filed
November 11, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11926657 Neutralizing anti-influenza binding molecules and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
